Home/Filings/4/0001209191-23-035381
4//SEC Filing

Gladstone Michael 4

Accession 0001209191-23-035381

CIK 0001923840other

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 4:17 PM ET

Size

6.0 KB

Accession

0001209191-23-035381

Insider Transaction Report

Form 4
Period: 2023-06-06
Gladstone Michael
Director10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2023-06-06+16,25016,250 total
    Exercise: $5.03Exp: 2033-06-05Common Stock (16,250 underlying)
Footnotes (2)
  • [F1]The option will vest in full on the earlier of (a) June 6, 2024 and (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date.
  • [F2]The Reporting Person is a member of Atlas Venture Life Science Advisors, LLC ("Atlas") and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the option to Atlas. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.

Issuer

Third Harmonic Bio, Inc.

CIK 0001923840

Entity typeother

Related Parties

1
  • filerCIK 0001864256

Filing Metadata

Form type
4
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 4:17 PM ET
Size
6.0 KB